Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket

Author: Lisa Levin | March 28, 2023 08:33am

Gainers

  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday.
  • Codiak BioSciences, Inc. (NASDAQ:CDAK) gained 27% to $0.2419 in pre-market trading. Codiak BioSciences shares dropped around 57% on Monday after the company voluntarily filed for protection under Chapter 11 bankruptcy.
  • Bird Global, Inc. (NASDAQ:BRDS) gained 20.4% to $0.1641 in pre-market trading. Bird, on Monday, announced purchases of shares by management and directors.
  • Accelerate Diagnostics, Inc. (NASDAQ:AXDX) climbed 16% to $0.58 in pre-market trading. Accelerate Diagnostics will host a conference call on March 29, 2023 to review fourth quarter and full year results.
  • PVH Corp. (NYSE:PVH) rose 12.3% to $82.65 in pre-market after the company posted better-than-expected results for its fourth quarter and issued strong FY23 earnings forecast.
  • Lion Group Holding Ltd. (NASDAQ:LGHL) gained 10% to $0.2830 in pre-market trading after gaining around 7% on Monday.
  • Silvergate Capital Corporation (NYSE:SI) shares rose 9.1% to $2.15 in pre-market trading. Silvergate Capital shares gained around 15% on Monday after MacroStrategy reported it voluntarily prepaid its Silvergate Bank loan. MicroStrategy prepaid approximately $161.0 million.
  • View, Inc. (NASDAQ:VIEW) shares rose 9% to $0.58 in pre-market trading.
  • Dermata Therapeutics, Inc. (NASDAQ:DRMA) rose 7.9% to $1.50 in pre-market trading after declining around 10% on Monday. Dermata Therapeutics recently announced closing of $5.0 million public offering.
  • Cidara Therapeutics, Inc. (NASDAQ:CDTX) shares rose 7.9% to $1.09 in pre-market trading. Cidara Therapeutics President and CEO Jeffrey Stein acquired a total 50,000 shares at an average price of $1.04.

Losers

  • WiSA Technologies, Inc. (NASDAQ:WISA) fell 21.7% to $2.82 in pre-market trading after jumping around 89% on Monday.
  • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) shares dropped 14.2% to $0.46 in pre-market trading. Virgin Orbit is extending its pause in operation to pursue investment, CNBC reported, citing a company-wide mail by CEO Dan Hart.
  • CytomX Therapeutics, Inc. (NASDAQ:CTMX) fell 11.7% to $1.58 in pre-market trading after the company posted results for its fourth quarter.
  • Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) fell 9.8% to $0.92 in pre-market. Citius Pharmaceuticals, last month, posted a Q1 loss of $0.02 per share.
  • Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) fell 9.2% to $0.4302 in pre-market trading after gaining over 5% on Monday.
  • OncoSec Medical Incorporated (NASDAQ:ONCS) shares fell 8.7% to $2.41 in pre-market trading.
  • FreightCar America, Inc. (NASDAQ:RAIL) fell 7.9% to $2.93 in pre-market trading. FreightCar America posted a wider-than-expected loss for its fourth quarter, but sales topped estimates. The company also said it sees FY23 revenue of $400 million to $430 million.
  • Sidus Space, Inc. (NASDAQ:SIDU) shares fell 7.6% to $0.5082 in pre-market trading. Sidus Space filed for common stock offering on Monday.
  • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) fell 5.9% to $0.4801 in pre-market trading.
  • Invesco Mortgage Capital Inc. (NYSE:IVR) fell 4.6% to $10.69 in pre-market trading after the company announced a cash dividend of $0.40 per share of common stock for the first quarter and issued an update on estimated results of operations, portfolio, liquidity and book value.

Now Read This: Investor Fear Eases As Dow Jumps Around 200 Points

Posted In: AXDX BDRX BRDS CDAK CDTX CTMX CTXR DRMA FRSX IVR LGHL ONCS PVH QNRX RAIL SI SIDU VIEW VORB WISA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist